Merck KGaA
Merck KGaA mulls splitting into three companies
17 May 2017
Fresenius to buy Merck’s biosimilars business for as much as €670 mn
25 April 2017
US FDA approves Merck KGaA and Pfizer drug for rare skin cancer
25 March 2017
Merck overhauls brand identity to communicate new direction
17 October 2015
Merck KGaA extends buyout offer period for AZ Electronic Materials
17 February 2014
Dr. Reddy’s Laboratories, Merck Serono to develop biosimilars
06 June 2012
Merck to pay Threshold up to $525 million for cancer drug development
06 February 2012
Merck KGaA sells women’s health business to Teva for €285 million
30 October 2010
Merck KGaA beats Thermo Fisher to acquire Millipore for $7.2 billion
02 March 2010
Merck KGaA acquires Banagalore bioscience firm
13 October 2009
Mylan Inc. acquires Merck KGaA's central eastern European generics businesses
02 June 2008
BASF, Bosch, Merck, Schott in organic photovoltaics
30 June 2007
Mylan Laboratories to acquire Merck generics unit for $6.6 billion
14 May 2007
Is Torrent a serious contender for Merck?
23 March 2007
Ranbaxy Laboratories Bids for Merck''s Generic Unit
13 March 2007
Private equity firms' bid plans boosts Merck group shares
09 March 2007
Ranbaxy plans ADS offering to finance Merck arm acquisition
21 February 2007
Aurigene, Merck Serono collaborate on therapeutics for autoimmune disorders
06 February 2007
Ranbaxy pitted against Texas Pacific, Cinven, Permira for Merck''s generic-drug unit
12 January 2007
Merck pays Glenmark Rs148 crore upfront for diabetes drug
19 December 2006
 search domain-b